Donald Mc Cain, MD
Surgical Oncology · Hackensack, NJNPI 1295801157
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (30.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 60.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $4,007 and has fallen 97.3% since, to $107 in 2025.
Across 27 payments — averaging $247.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$4K
- Intuitive Surgical$2K
- Sanara Medtech Inc.$115
- Medtronic$115
- Johnson & Johnson$37
- Davol Inc.$28
- plus $17 from 1 others
What the payments were for
- Consulting fees$2,00030%
- Travel & lodging$1,89928%
- Food & beverage$1,75326%
- Education$1,00015%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 10 | $4,012 |
| Intuitive Surgical | 11 | $2,345 |
| Sanara Medtech Inc. | 1 | $115 |
| Medtronic | 1 | $115 |
| Johnson & Johnson(2 entities) | 2 | $37 |
| Davol Inc. | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$10,516
- Kerecis Omega3 Marigen$5,301
- Kerecis Omega3 GraftGuide$3,710
- Da Vinci Surgical System$1,156
- DAVINCI XI$1,000
- CellerateRx$115
- Signia$115
How this compares
$6,669 in reported general payments places this provider in the 80th percentile of 59 surgical oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 20 | $1,381 |
| Azithromycin | 123 | $417 |
| Tramadol Hcl | 115 | $180 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $134 |
| Oxycodone Hcl | 34 | $114 |
| Ciprofloxacin Hcl | 25 | $31 |
| Metronidazole | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Hackensack
- Marson DavidsonHackensack$6K
- Christopher McGreevyHackensack$1K
- Martin KarpehHackensack$1K
- Thangamani SeenivasanSomerville$22K
- John CunninghamBerkeley Heights$20K
- Manpreet KohliLong Branch$20K
- Haejin InNew Brunswick$12K
- Anjeanette BrownCape May Court House$11K
- Marc FromerBrick$9K
- Russell LanganLivingston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.